Clorox Co (CLX) Holdings Reduced by Toth Financial Advisory Corp

Toth Financial Advisory Corp lowered its holdings in Clorox Co (NYSE:CLX) by 1.9% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 26,456 shares of the company’s stock after selling 506 shares during the quarter. Toth Financial Advisory Corp’s holdings in Clorox were worth $4,245,000 as of its most recent filing with the SEC.

Other institutional investors have also added to or reduced their stakes in the company. Visionary Asset Management Inc. acquired a new position in shares of Clorox during the 4th quarter worth $225,000. Phocas Financial Corp. acquired a new position in Clorox in the 4th quarter valued at about $193,000. Oregon Public Employees Retirement Fund raised its stake in Clorox by 48,033.6% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 6,808,980 shares of the company’s stock valued at $44,000 after purchasing an additional 6,794,834 shares during the last quarter. Montecito Bank & Trust raised its stake in Clorox by 24.0% in the 1st quarter. Montecito Bank & Trust now owns 5,212 shares of the company’s stock valued at $836,000 after purchasing an additional 1,009 shares during the last quarter. Finally, W.E. Donoghue & Co. LLC acquired a new position in Clorox in the 4th quarter valued at about $2,482,000. 76.89% of the stock is owned by institutional investors.

CLX traded down $1.04 during midday trading on Monday, hitting $154.45. The company’s stock had a trading volume of 772,492 shares, compared to its average volume of 990,674. The company has a debt-to-equity ratio of 3.08, a current ratio of 1.15 and a quick ratio of 0.66. The stock has a market capitalization of $19.87 billion, a price-to-earnings ratio of 24.67, a price-to-earnings-growth ratio of 3.87 and a beta of 0.32. Clorox Co has a 52-week low of $113.57 and a 52-week high of $167.70.



Clorox (NYSE:CLX) last posted its quarterly earnings results on Monday, February 4th. The company reported $1.40 EPS for the quarter, beating the consensus estimate of $1.32 by $0.08. The company had revenue of $1.47 billion during the quarter, compared to analysts’ expectations of $1.47 billion. Clorox had a return on equity of 105.97% and a net margin of 12.65%. The firm’s revenue was up 4.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.77 EPS. Equities research analysts anticipate that Clorox Co will post 6.31 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be issued a dividend of $0.96 per share. This represents a $3.84 dividend on an annualized basis and a dividend yield of 2.49%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox’s payout ratio is currently 61.34%.

In other news, SVP Andrew J. Mowery sold 5,340 shares of the business’s stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $156.44, for a total transaction of $835,389.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Matthew T. Laszlo sold 10,585 shares of the business’s stock in a transaction dated Wednesday, February 6th. The stock was sold at an average price of $153.89, for a total value of $1,628,925.65. Following the sale, the senior vice president now owns 17,994 shares of the company’s stock, valued at approximately $2,769,096.66. The disclosure for this sale can be found here. 1.40% of the stock is currently owned by insiders.

Several brokerages recently weighed in on CLX. Zacks Investment Research raised shares of Clorox from a “sell” rating to a “hold” rating in a research note on Monday, January 7th. Wells Fargo & Co reissued a “hold” rating and issued a $157.00 target price on shares of Clorox in a research note on Monday, February 4th. Morgan Stanley set a $142.00 target price on shares of Clorox and gave the company a “sell” rating in a research note on Thursday, December 20th. JPMorgan Chase & Co. downgraded shares of Clorox from a “neutral” rating to an “underweight” rating and cut their target price for the company from $159.00 to $139.00 in a research note on Monday, April 8th. Finally, Citigroup set a $171.00 target price on shares of Clorox and gave the company a “hold” rating in a research note on Tuesday, February 5th. Six equities research analysts have rated the stock with a sell rating, five have issued a hold rating and four have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $151.21.

TRADEMARK VIOLATION NOTICE: This news story was originally posted by Dakota Financial News and is owned by of Dakota Financial News. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international trademark & copyright laws. The correct version of this news story can be accessed at https://dakotafinancialnews.com/2019/04/15/clorox-co-clx-holdings-reduced-by-toth-financial-advisory-corp.html.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Further Reading: Trading based on a resistance level

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.